Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children

January 7, 2011 updated by: Wageningen University

Calcium, Probiotics and Acute Diarrheal Disease Among Indonesian Children Aged 1-6 Years in Low Socio-economic Urban Area of East Jakarta

This is a long term study on the efficacy of dietary calcium with or without probiotic strains in reducing the mean number of episodes and duration of diarrheal disease.

Study Overview

Study Type

Interventional

Enrollment (Actual)

494

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jakarta, Indonesia, 10430
        • Seameo-Tropmed Rccn Ui

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 6 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Apparently healthy children aged 1-6 years, with emphasize on aged 2-5 years, living permanently in low socio-economic urban areas of East Jakarta for at least 6 months
  • Parents are willing to sign the informed consent and give the supplements to the children for the period of 6 months
  • Capable and willing to drink liquid milk with a straw (acceptance to be tested at screening by providing a sample drink and placebo straw to be consumed under supervision for 2 days)

Exclusion Criteria:

  • Calcium intake exceeding 75% of the RDA for calcium (<375 mg/d) based on a Food Frequency Questionnaire
  • Currently breastfed children
  • Siblings of already included children that are living in the same household, except if it is a twin sibling
  • Severely malnourished with or without oedema (Weight for height-WHZ Z-score of <-3.00 SD)
  • Symptoms of chronic/congenital diseases and disabilities, suspected Tuberculosis by clinical examination, and /or history of allergic disease.
  • Taking (any) antibiotics during 2 weeks prior to start of the study (children will be included after 3 weeks of last antibiotic intake
  • Participation in another clinical trial at the same time or 2 months prior to the start of this study
  • Both mothers and other caregivers present in the family are illiterate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 2
twice daily for 24 weeks
Placebo Comparator: 1
twice daily for 24 weeks
Active Comparator: 3
twice daily for 24 weeks
Active Comparator: 4
twice daily for 24 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The mean number of episodes and duration of acute diarrheal disease
Time Frame: 24 weeks
24 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Incidence of acute diarrheal disease
Time Frame: 24 weeks
24 weeks
Severity of acute diarrheal disease
Time Frame: 24 weeks
24 weeks
Intestinal and systemic inflammation
Time Frame: 24 weeks
24 weeks
Intestinal colonization with pathogenic bacteria or viruses
Time Frame: 24 weeks
24 weeks
Nutritional status based on anthropometric measurement
Time Frame: 24 weeks
24 weeks
Iron and zinc status
Time Frame: 24 weeks
24 weeks
Incidence, mean episodes and duration of acute respiratory infections
Time Frame: 24 weeks
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rina Agustina, MD, Seameo-Tropmed Rccn Ui
  • Study Chair: Frans J. Kok, Prof, Division of Human Nutrition, Wageningen University (WUR)
  • Study Director: Ingeborg Bovee-Oudenhoven, PhD, TIFN/ NIZO Food Research
  • Study Chair: Agus Firmansyah, Prof, MD, Faculty of Medicine University of Indonesia
  • Study Director: Widjaja Lukito, MD, Seameo-Tropmed Rccn Ui

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

September 1, 2008

Study Completion (Actual)

September 1, 2008

Study Registration Dates

First Submitted

August 6, 2007

First Submitted That Met QC Criteria

August 7, 2007

First Posted (Estimate)

August 8, 2007

Study Record Updates

Last Update Posted (Estimate)

January 10, 2011

Last Update Submitted That Met QC Criteria

January 7, 2011

Last Verified

January 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on low calcium milk of 180 ml

Subscribe